Core Viewpoint - Betaini plans to invest 50 million yuan as a limited partner in the establishment of the Wuxi Jinyu Maowu Medical Health Industry Investment Partnership, aiming to deepen cooperation in the health ecosystem and enhance its competitive edge and profitability [1][5]. Investment Details - The total committed capital for the Jinyu Fund is 1 billion yuan, with Betaini holding a 5% partnership share after the investment [1]. - The fund's primary investment focus includes consumer healthcare, national health quality improvement, pharmaceuticals, medical devices, and AI in pharmaceuticals [2][6]. Historical Investment Background - Jinyu Maowu Investment Management Co., Ltd., the fund manager, has previously invested over 100 million yuan in Betaini since 2015 [6]. - Betaini has established and invested in nine fund companies since its listing in 2021, with planned investments exceeding 700 million yuan across various sectors including AI and consumer healthcare [7]. Financial Performance of Fund Manager - Jinyu Maowu reported a revenue of 84.46 million yuan in 2024, a year-on-year increase of 4.51%, while its net profit decreased by 68.21% to 51.61 million yuan [6]. - For the first half of 2024, the company achieved a revenue of 42.97 million yuan, a decrease of 2.36%, but its net profit rose by 75.35% to 44.24 million yuan [6]. Industry Trends - The medical beauty market in China is projected to grow significantly, reaching 399.8 billion yuan by 2026, indicating a strong growth potential in this sector [10]. - Betaini has formed a strategic partnership with Lumenis Group to develop home medical beauty devices, integrating its R&D capabilities with Lumenis' technology [11]. Recent Developments - Betaini's brand AOXMED has seen rapid growth, achieving a revenue of 51.47 million yuan in the first half of 2025, a year-on-year increase of 93.90% [11]. - The company has actively engaged in the medical beauty sector, with multiple investments and product launches aimed at enhancing its market presence [12].
贝泰妮参投新10亿级基金